Journal Article

Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin

Leelawong, Mindy, Ventocilla, Julio A., Tapia, L. Lorena, Wilder, Brandon K., Baldeviano, G. Christian, Ponce, Reynaldo, Franco, Adriano, Aguiar, Joao C.

2024

Overview

Background Plasmodium vivax represents the most geographically widespread human malaria parasite affecting civilian and military populations in endemic areas. Targeting the pre-erythrocytic (PE) stage of the parasite life cycle is especially appealing for developing P. vivax vaccines as it would prevent disease and transmission. Here, naturally acquired immunity to a panel of P. vivax PE antigens was explored, which may facilitate vaccine development and lead to a better understanding of naturally acquired PE immunity. Methods Twelve P. vivax PE antigens orthologous to a panel of P. falciparum antigens previously identified as highly immunogenic in protected subjects after immunization with radiation attenuated sporozoites (RAS) were used for evaluation of humoral and cellular immunity by ELISA and IFN-γ ELISpot. Samples from P. vivax infected individuals (n = 76) from a low endemic malaria region in the Peruvian Amazon Basin were used. Results In those clinical samples, all PE antigens evaluated showed positive IgG antibody reactivity with a variable prevalence of 58–99% in recently P. vivax diagnosed patients. The magnitude of the IgG antibody response against PE antigens was lower compared with blood stage antigens MSP1 and DBP-II, although antibody levels persisted better for PE antigens (average decrease of 6% for PE antigens and 43% for MSP1, p < 0.05). Higher IgG antibodies was associated with one or more previous malaria episodes only for blood stage antigens (p < 0.001). High IgG responders across PE and blood stage antigens showed significantly lower parasitaemia compared to low IgG responders (median 1,921 vs 4,663 par/µl, p < 0.05). In a subgroup of volunteers (n = 17),positive IFN-γ T cell response by ELISPOT was observed in 35% vs 9–35% against blood stage MSP1 and PE antigens, respectively, but no correlation with IgG responses . Conclusions These results demonstrate clear humoral and T cell responses against P. vivax PE antigens in individuals naturally infected with P. vivax. These data identify novel attractive PE antigens suitable for use in the potential development and selection of new malaria vaccine candidates which can be used as a part of malaria prevention strategies in civilian and military populations living in P. vivax endemic areas.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Adolescent / Adult / Aged / Analysis / Antibodies, Protozoan - blood / Antigen-antibody reactions / Antigens / Antigens, Protozoan - immunology / Biomedical and Life Sciences / Biomedicine / Child / Entomology / Enzyme-Linked Immunosorbent Assay / Enzyme-Linked Immunospot Assay / Female / Humans / Immune response / Immunoglobulin G / Immunoglobulin G - blood / Infectious Diseases / Malaria vaccine / Malaria, Vivax - epidemiology / Malaria, Vivax - immunology / Male / Medical research / Medicine, Experimental / Microbiology / Middle Aged / Natural acquired immunity / Parasitology / Peru - epidemiology / Peruvian amazon Basin / Physiological aspects / Plasmodium falciparum / Plasmodium vivax / Plasmodium vivax - immunology / Pre-erythrocytic stage / Proteins / Protozoan Proteins - immunology / Public Health / Tropical Medicine / Vaccines / Young Adult